• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Autophagy . Generation of live attenuated influenza vaccine through selective autophagy

tetano

Editor, Senior Moderator
Autophagy


. 2026 May 10:1-2.
doi: 10.1080/15548627.2026.2669366. Online ahead of print.
Generation of live attenuated influenza vaccine through selective autophagy

Jiawei Hao[SUP] 1 [/SUP], Longlong Si[SUP] 1 2 [/SUP]


Affiliations
Abstract

Manipulating viral protein stability and degradation is a promising strategy to conditionally regulate viral replication, thereby converting viruses into live whole-virion vaccines. Recently, we developed a live attenuated vaccine approach based on the autophagy-lysosomal degradation pathway. By incorporating an autophagosome-targeting motif (ATM) into the influenza A virus genome, we generated an autophagy-targeting (AUTOTAR) virus that is highly attenuated in conventional cells but retains efficient replication capacity in engineered production cells. Despite this attenuation, the AUTOTAR virus elicits strong humoral, mucosal, and cellular immune responses and confers complete protection against both homologous and heterologous viral challenges. These findings establish selective autophagy as a rational and tunable strategy for live vaccine design.

Keywords: selective autophagy; influenza A virus; live attenuated vaccine; viral protein degradation; ATG8;.

 
Back
Top